SYMBIOSIS LLC

SymBiosis LLC is a biotech-focused investment vehicle.

#SimilarOrganizations #Financial #More

SYMBIOSIS LLC

Status:
Active


Similar Organizations

logos-capital-logo

Logos Capital

Logos Capital is a fundamental biotechnology-focused investment fund.

Investments List

Date Company Article Money raised
2022-01-05 SalioGen Therapeutics SymBiosis LLC investment in Series B - SalioGen Therapeutics 115 M USD
2021-11-04 Platelet BioGenesis SymBiosis LLC investment in Series B - Platelet BioGenesis 75.5 M USD
2021-07-21 Vedanta Biosciences SymBiosis LLC investment in Series D - Vedanta Biosciences 43 M USD
2021-03-02 EGenesis SymBiosis LLC investment in Series C - EGenesis 125 M USD
2021-03-01 Carisma Therapeutics SymBiosis LLC investment in Series B - Carisma Therapeutics 12 M USD
2021-02-17 Micronoma SymBiosis LLC investment in Convertible Note - Micronoma 3.5 M USD
2021-02-11 Ensoma SymBiosis LLC investment in Series A - Ensoma 70 M USD
2021-01-07 Carisma Therapeutics SymBiosis LLC investment in Series B - Carisma Therapeutics 47 M USD
2020-12-30 Clene Nanomedicine SymBiosis LLC investment in Post-IPO Equity - Clene Nanomedicine 22.4 M USD
2020-09-22 Siolta Therapeutics SymBiosis LLC investment in Series B - Siolta Therapeutics 30 M USD

More informations about "SymBiosis LLC" on Search Engine